|Coordinate||52,640,733 bp (GRCm38)|
|Base Change||A ⇒ G (forward strand)|
|Gene Name||spleen tyrosine kinase|
|Chromosomal Location||52,583,173-52,648,792 bp (+)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the family of non-receptor type Tyr protein kinases. This protein is widely expressed in hematopoietic cells and is involved in coupling activated immunoreceptors to downstream signaling events that mediate diverse cellular responses, including proliferation, differentiation, and phagocytosis. It is thought to be a modulator of epithelial cell growth and a potential tumour suppressor in human breast carcinomas. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
PHENOTYPE: Homozygous null mice have high rates of postnatal lethality, exhibit developmental defects of B cells, T cells and osteoclasts, and have defective dendritic cell cross-presentation of antigens from necrotic cells. [provided by MGI curators]
|Amino Acid Change||Tyrosine changed to Cysteine|
|Institutional Source||Beutler Lab|
|Gene Model||predicted gene model for protein(s): [ENSMUSP00000060828] [ENSMUSP00000112914] [ENSMUSP00000113852]|
AA Change: Y501C
|Predicted Effect||possibly damaging
PolyPhen 2 Score 0.798 (Sensitivity: 0.84; Specificity: 0.93)
AA Change: Y478C
|Predicted Effect||probably damaging
PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
AA Change: Y501C
|Predicted Effect||possibly damaging
PolyPhen 2 Score 0.798 (Sensitivity: 0.84; Specificity: 0.93)
|Meta Mutation Damage Score||0.5571|
|Is this an essential gene?||Essential (E-score: 1.000)|
|Candidate Explorer Status||CE: failed initial filter|
Linkage Analysis Data
|Alleles Listed at MGI|
|Mode of Inheritance||Autosomal Recessive|
|Local Stock||Live Mice|
|Last Updated||2019-10-23 1:57 PM by Anne Murray|
|Record Created||2013-02-01 12:40 AM by Ying Wang|
The poppy phenotype was initially identified by flow cytometric analysis of peripheral blood from G3 mice carrying mutations induced by N-ethyl-N-nitrosourea (ENU). The index poppy mice (T2313, T2314, and T2315) were deficient in B cells; neutrophil numbers were increased (Figure 1 & 2). Peritoneal macrophages from poppy mice exhibited hypersensitivity to the Toll-like receptor (TLR) agonists LPS, MALP2 and R848 as determined by increased secretion of TNFα compared to wild type macrophages (Figure 3).
|Nature of Mutation|
Whole exome HiSeq sequencing of the G1 grandsire identified 56 mutations. Seventeen G3 mice from the poppy pedigree were genotyped at all 56 mutation sites. Among six mice with the poppy phenotype, five were homozygous and one was heterozygous for a mutation in Syk on chromosome 13. Among eleven unaffected mice, eight were either heterozygous or wild type at the Syk locus, while three were homozygous for the Syk mutation, indicating that the poppy phenotype is recessive and incompletely penetrant. These data resulted in a LOD score of 5.30. The mutation is an A to G transition at base pair 52640733 (v38) on Chromosome 13 in the GenBank genomic region NC_000079 encoding Syk. The mutation corresponds to residue 1718 in the NM_011518 mRNA sequence and 1714 in the NM_001198977 mRNA sequence within exon 11 of 14 total exons.
The mutated nucleotide is indicated in red. The mutation results in a tyrosine (Y) to cysteine (C) substitution at residue 501.
|Illustration of Mutations in
Gene & Protein
Syk encodes spleen tyrosine kinase (Syk), one of two members of the Syk family of cytosolic protein kinases. The second Syk family member is zeta-chain-associated protein kinase 70 (Zap70) (see the records for murdock, trebia, wanna, and mrtless). Syk and Zap70 both have two Src homology 2 (SH2) domains and a C-terminal kinase region followed by a short C-terminal tail [Figure 4; reviewed in (1-3)]. Between the SH2 domains is interdomain A; between the C-terminal SH2 domain and the kinase domain is interdomain B [(4); reviewed in (1-3)].
The SH2 domains recognize and bind diphosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs; (Asp/Glu)-X-X-Tyr-X-X-Leu/Iso-(X)6-12-Tyr-X-X-Leu/Iso) or hemi-ITAMs (i.e,. contain one Tyr) in a target protein as well as β3-integrin (ITAM-independent) to initiate downstream signaling [reviewed in (1-3;5;6)]. The SH2 domains of Syk have a conformational flexibility that can recognize the relative distance between phosphotyrosines of an ITAM and adjust the orientation of the SH2 domains to fit that spacing [(7); reviewed in (5)]. The flexibility of the SH2 domains allows for Syk to interact with several different immunoreceptors (e.g., B- and T-cell antigen receptors and Natural Killer (NK)-cell receptors) and, possibly, some G-protein-coupled receptors [reviewed in (5)].
Interdomain A facilitates the proper conformation of the SH2 domains to promote binding to phosphorylated ITAMs using a helical coiled-coil structure [reviewed in (1;2)]. In addition, the C-terminal portion of interdomain A is critical for calcium mobilization via B cell receptor (BCR) signaling (8).
Interdomain B contains five putative autophosphorylation sites and functions to recruit, and dock, downstream signaling proteins (e.g., phospholipase Cγ1 (PLCγ1), Vav1 and c-Cbl) as well as regulate the ability of Syk to bind to ITAMs [(9-13); reviewed in (1;2;14)]. Interdomain B also contains a non-canonical nuclear localization signal that permits Syk to shuttle between the nucleus and cytoplasm (15;16). A splice variant of Syk, SykB, lacks 23 amino acids of interdomain B, a sequence necessary for maximal ITAM binding by Syk [(12;15;17)]. SykB has comparable enzymatic activity to that of Syk, but is less efficient in coupling to phosphorylated ITAMs such as those of the FcγRI receptor of mast cells [(12); reviewed in (1;14)].
The Syk kinases are maintained in a closed, inactive conformation by interactions between residues in interdomain A, interdomain B, and the kinase domain (36;38;39). The C-terminal region of interdomain A contains residues important for maintaining the resting state [(8); reviewed in (2)]. In the inactive conformation, the SH2 domains are not aligned for ITAM binding and the kinase domain cannot perform the phospho-transfer reaction (36). Either phosphorylation of interdomain A/B tyrosines or binding of phosphorylated ITAMs to SH2 domains can release the inhibitory interactions that hold Syk in an inactive state, thereby permitting ATP and substrates access to the active site and stimulating Syk kinase activity (36;37;39).
The crystal structure of the kinase domain of human Syk (amino acids 353-635) has been solved [Figure 5; PDB: 1XBA; (40)]. The N-terminal lobe of the kinase domain is composed of a five-stranded β-sheet and a single α-helix, while the C-terminal lobe is largely α-helical with three short β-strands; the active site is between the two lobes (40). Unphosphorylated Syk kinase domain forms a loop-out conformation similar to what is seen in active, phosphorylated protein kinases, indicating that activation loop phosphorylation is not required for Syk kinase activity. A recent study crystalized full-length human Syk at 2.2 Å [Figure 6; PDB:4FL3; (41)]. In this structure, the topology of the Syk kinase domain is similar to inactive kinase domains. The interdomain linkers (helices αL1, αL2, and αL3) bind to helices αE and αI of the kinase domain, consistent with previous data supporting an autoinhibited conformation maintained by interactions between interdomains A and B, and the kinase domain. The SH2 domains each consist of a β-sheet flanked by two α-helices and the linkers consist of three α-helices to form a helical coiled coil (41).
The poppy mutation is a tyrosine to cysteine substitution at amino acid 501 within the C-terminal kinase domain.
Syk is highly expressed in hematopoietic cells including B cells, immature T cells, mast cells, dendritic cells, basophils, osteoclasts, leukocytes, neutrophils, macrophages, and platelets [reviewed in (1-3)]. Syk is also expressed in non-hematopoietic cells including fibroblasts (embryonic and nasal), epithelial cells (breast and airway), hepatocytes, neuronal cells, and vascular endothelial cells, red blood cells, and synoviocytes (4).
In B cells, Syk is localized to both nuclear and cytoplasmic compartments [reviewed in (1)]. The mechanism by which Syk is transported between the nucleus and cytoplasm is unknown, but interdomain B is essential for this to occur (16). Upon BCR aggregation, Syk is recruited to the plasma membrane [(42); reviewed in (1)].
Reduction in Syk mRNA and protein expression has been documented in several types of cancers including breast, gastric, melanoma, squamous cell carcinoma, pro-B cell acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic lymphocytic leukemia (CLL) [(43-47); reviewed in (48)].
Syk plays a major role in B cell development as a component of the pre-BCR and BCR signaling pathways, and no mature B cells are found in mice with targeted null mutations of Syk (49-51). In BCR signaling, following the aggregation of BCR molecules, the ITAMs in the tails of Igα and Igβ become phosphorylated by Src family kinases (typically Lyn) [Figure 7; (52;53)]. These phosphotyrosines then act as docking sites for the SH2 domains of Syk, resulting in Syk phosphorylation and activation. Syk phosphorylates a number of downstream targets including BLNK (see the record for busy), PLCγ2 (see the record for queen), and protein kinase C β (PKCβ; see the record for Untied). BCR stimulation also activates phosphatidylinositol 3 kinase (PI3K) resulting in the generation of PIP3, which binds selectively to the pleckstrin homology domain of Btk, facilitating membrane recruitment of the kinase. Phosphorylated BLNK also provides docking sites for Btk, as well as PLCγ2, which results in the additional phosphorylation and activation of PLCγ2 by Btk leading to the hydrolysis of phosphatidylinositol-3,4-diphosphate (PIP2) to inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) (54). The recruitment of Vav1, Nck and Ras by BLNK to the BCR activates MAP kinase cascades such as JNK, p38 and extracellular signal regulated kinase (ERK) [reviewed in (55)]. Together, these signals allow the activation of multiple transcription factors, including nuclear factor of activated T cells (NF-AT), NF-κB (see the records for puff, xander and panr2) and AP-1, which subsequently regulate biological responses including cell proliferation, differentiation, and apoptosis as well as the secretion of antigen-specific antibodies [reviewed in (56)]. Other molecules that play important roles in BCR signaling include Bcl10, mucosa-associated lymphoid tissue translocation gene 1 (Malt1), and caspase recruitment domain family, member 11 (CARMA1, alternatively Card11; see the record for king), which are involved in NF-κB activation along with PKCβ (57-60).
Syk couples pre-BCR and BCR activation to downstream signaling pathways that mediate B cell development, proliferation, and survival (Figure 7). Pre-BCR engagement results in the activation of Syk, which together with Src-family kinases (Lyn, Fyn, Blk), phosphorylates many substrates (see Table 1) and triggers signaling pathways that are involved in both proliferation and differentiation of pre-B cells (52;53). These include activation of phosphoinositide 3 kinase (PI3K) by phosphorylating the coreceptor CD19 and/or the adaptor protein B-cell PI3K adaptor (BCAP; see the record for sothe) (61). PI3K activation results in the generation of phosphatidylinositol-3,4,5-triphosphate (PIP3), which recruits plekstrin-homology domain signaling molecules to the membrane including the serine threonine protein kinase B (PKB) and its activating kinase 3-phosphoinositide-dependent protein kinase 1 (PDK1). Signaling through this pathway suppresses recombination-activating gene 1 (RAG1; see the record for maladaptive) and RAG2 expression (in VDJ recombination in pro-B cells), blocks Igκ (the kappa chain of the immunoglobin light chain) gene recombination, and induces cell proliferation. Syk also phosphorylates SH2-domain containing leukocyte protein of SLP65, resulting in the organization of a molecular complex that includes Bruton’s tyrosine kinase (BTK) and PLCγ2 (54). This complex controls downregulation of l-5, a component of the surrogate light chain (SLC), and upregulates the expression of RAG proteins and the interferon-regulatory factor 4 (IRF4). IRF4 positively regulates Igκ recombination. SLP65 also modulates PKB activity either directly or by altering the activity of Syk, CD19, or PI3K. Alternatively, SLP65 may regulate PKB activity by activating lipid phosphatases such as SH2-domain containing inositol-5 phosphate (SHIP; see the record for styx) and altering PIP3 levels.
Table 1. Select substrates of Syk* [modified from (1)]
*List is not comprehensive
Syk in other immune cell ITAM pathways
In addition to its role in BCR signaling, Syk also functions in pre-TCR signaling in thymocytes during the transition from the DN3 to the DN4 stage of development (89), and during TCR signaling in mature T cell populations (intraepithelial γδ T cells and naïve αβ T cells) (Table 2) (90;91). However, Zap70 is the major Syk family kinase in TCR signaling.
Syk functions in ITAM-associated signaling in other immune cells including natural killer cells downstream from the FcγRIII receptor (92), in mast cells downstream from the FcεRI receptor (11;13), and in neutrophils and macrophages downstream from FcγR signaling [Figure 8 and Table 2; (93;94)]. Although ligand recognition differs among these receptors, the intracellular pathways are highly conserved: activated Src family kinases (e.g., Hck, Fgr, Lyn, or Src) recruit Syk to the receptor-associated ITAMs [reviewed in (3;95)]. Activated Syk subsequently phosphorylates a number of proteins including SLP76, SLP65, Vav1, PLCγ, and the p85α subunit of PI3K (see Table 1). These proteins activate downstream signaling components to trigger several cellular responses including proliferation, differentiation, cell survival, mast cell degranulation, reactive oxygen species (ROS) production, phagocytosis, and cytokine release [reviewed in (2;3)].
A role for Syk in numerous non-immune cells has also been demonstrated (Table 2).
Syk signaling via hemi-ITAMs
Syk can also bind to hemi-ITAMs (i.e., ITAM motifs containing one YxxL motif) in C-type lectin receptors including the C-type lectin-like protein type 2 (CLEC2) receptor, CLEC9A, and Dectin-1 (96). CLEC2 functions in the developmental separation of blood and lymphatic vessels (97;98), while Dectin-1 induces intracellular signaling upon recognition of fungal pathogens (99). The C-type lectin and BCR signaling pathways share many of the same downstream components, including PLCγ2 (96).
Syk-associated signaling via ITAM-signaling adaptors
Syk can also signal through ITAM-containing adaptors (e.g., DNAX activation protein-12 (DAP12) and FcRγ) that associate with immunoglobulin superfamily-containing proteins [e.g., Fc receptors, PIR-A, OSCAR, GPVI, or triggering receptor expressed on myeloid cells (TREM) (100;101)], C-type lectin receptors [e.g., Dectin-2, Mincle, or MDL-1 (102;103)], and cytokine receptors [e.g., macrophage colony-stimulating factor (M-CSF) (104;105)], as well as integrins (106;107). DAP12, FcRγ, and their associated receptors are found in several cell types including neutrophils, macrophages, monocytes, dendritic cells, basophils, eosinophils, mast cells, NK cells, microglia, osteoclasts, megakaryocytes, and platelets [reviewed in (108)]. Signaling via the ITAM-containing adaptors and their associated receptors is similar to ITAM receptor signaling. Syk-mediated activation of PLCγ2 and CARD9 leads to the activation of NF-κB and MAPKs [reviewed in (109)]. Signaling via the ITAM-signaling adaptors mediates phagocytosis (110) and osteoclast development (111) as well as cell proliferation and survival (105).
The ITAM-associated receptors and TLRs activate distinct signaling pathways, but the two pathways can cross-talk to activate NF-κB and the MAPKs. For example, Syk activation and association with DAP12-TREM can either amplify or dampen TLR-induced signals in a ligand-dependent manner during an inflammatory response, possibly through the CARD complex or the activation of ERK (112).
Integrins are known to signal via Syk in a pathway similar to that used by ITAM-associated immunoreceptors. For example, in platelets, activation of αIIbβ3 integrin (in association with the ITAM-containing receptor FcγRIIA) can activate Syk, subsequently leading to platelet activation through SLP76 and PLCγ2 [reviewed in (3)]. However, some evidence suggests that integrins activate Syk in an ITAM-independent manner, through direct binding between Syk and the integrin β chain [reviewed in (3)].
Table 2. Syk is a multi-functional kinase [modified from (5)]
Syk signaling affects several tumor cell activities including cell division, cell survival, 3-D cell outgrowth, cell migration, neuron-like cell differentiation, phagocytosis, and cell adhesion (47;48;133;134). Syk is expressed in human breast tissue and benign breast tumors, but is undetectable or expressed at low levels in invasive breast tumors and cell lines (47). Syk transfection into a Syk-negative breast cancer cell line resulted in inhibition of tumor growth and metastasis in athymic mice (47). In addition, overexpression of a kinase-deficient Syk in a Syk-expressing breast cancer cell line increased the incidence and growth of tumors (47). Thus, Cooper et al. propose that Syk functions as a tumor suppressor in human breast carcinomas (47). Consistent with this hypothesis, reduced amounts of SYK mRNA expression in breast cancer tissue relative to adjacent non-cancerous tissue were correlated with increased incidence of distant metastasis, translating to poor prognosis (135). Syk has been shown to regulate mammalian target of rapamycin (mTOR) and MAPK signaling in AML (44) and in B cell lymphoma (48;49). Syk is activated in CLL (45;46), a condition characterized by the expansion of monoclonal, mature B cells [reviewed in (136)], and regulates the survival of CLL B cells (137). Syk inhibition can suppress CLL B cell activation and migration (43).
Syk null mouse models
Syk deficiency in homozygous Syk knockout mouse models (MGI:1857421, MGI:2384078, and MGI: 3690645) leads to the absence of mature B cells due to abnormal B cell differentiation (49-51). Homozygotes exhibited early postnatal lethality (49;51) with a concomitant defect in blood vessel morphology, dilated vasculature, and systemic hemorrhage in the embryo (49;51;98;141). Further observation of homozygous Syktm1Tyb mice (MGI:2384078) found that the model exhibited defective osteoclast differentiation (111), decreased bone resorption (111), decreased TNF secretion from neutrophils after 16-hour culture with S. aureus or E. coli (142), impaired lymphatic vessel morphology in the lungs and brain [i.e., there is a connection between the vasculature and lymphatic systems; (98)], impaired neutrophil degranulation in response to S. aureus and E. coli (142), impaired neutrophil phagocytosis of bacteria (142), reduced T cell number in the skin (49), and inefficient CD8α+ dendritic cell antigen cross-presentation (143).
Consistent with an essential role for Syk in BCR signaling, B cell proliferation, and B cell differentiation (49;50;144), homozygous poppy mice are B cell-deficient. However, homozygous poppy mice are born at expected Mendelian ratios and survive to adulthood, indicating that the poppy allele retains sufficient functionality to support postnatal survival.
The role of Syk in TLR-mediated signaling is unclear. The poppy mutation results in an increase in macrophage TNFα secretion upon treatment with the TLR agonists MALP2 (TLR2/6) and R848 (TLR7). Studies have documented elevated TLR4-, TLR3-, and TLR9-mediated signaling in Syk-deficient macrophages, leading to a subsequent increase in TNF production relative to wild type macrophages (145). However, the role of Syk in TLR2/6, TLR7 or TLR8 signaling has not been documented.
Some evidence suggest that TLR or TNF receptor activation leads to integrin activation [(88;146); reviewed in (109)], subsequently causing the integrins to assume a conformation that promotes high-affinity ligand-binding in a process known as ‘inside-out’ signaling (147;148). Inside-out signaling promotes increased adhesion to the extracellular matrix, cell spreading and enhanced cell-cell interactions. The increased integrin ligand affinity also results in high-avidity ligation of integrins and the subsequent generation of an integrin-mediated ‘outside-in’ signal. The outside-in signal of β2 and β3 integrins is propagated by DAP12 and FcRγ, which recruit Syk to their phosphorylated ITAMs.
Published data currently support two distinct mechanisms by which Syk may negatively regulate TLR signaling. First, Syk interacts with, and induces the phosphorylation of, the TLR adapters MyD88 and TRIF (88). Phosphorylation of MyD88 and TRIF subsequently results in c-Cbl-induced ubiquitination and degradation of Syk (88). Second, β2 integrins and FcγRs in macrophages signal via the ITAM-containing adaptor DAP12 and Syk to inhibit TLR signaling through the induction of IL-10 and the TLR signaling inhibitors SOCS3, ABIN-3, and A20 (149). Notably, DAP12-deficient macrophages also displayed elevated TNF production in response to TLR ligands (145), supporting a DAP12 negative regulatory signaling cascade involving Syk that inhibits TLR signaling.
These findings contrast with data supporting a positive role for Syk in TLR signaling. In one study, Syk phosphorylation was induced in THP1 human monocytes upon TLR9 activation, subsequently leading to cell migration, adhesion, and secretion of IFNα and IL-6 (150). In another study, LPS stimulation of murine macrophages induced Syk phosphorylation and the expression of inflammatory genes (151). Piceatannol, a Syk inhibitor, as well as Syk inhibition by antisense oligonucleotides resulted in attenuation of the LPS-induced events in macrophages (151;152). Lin et al. examined the role of Syk in TLR9, -3, and -4-mediated signaling by using Syk inhibitors (SykI and BAY61-3606) in TLR-stimulated RAW 264.7 macrophages and primary bone marrow-derived macrophages (BMDM) (153). They found that pharmacological inhibition of Syk in the RAW 264.7 macrophages resulted in an inhibitory effect on TLR-induced JNK activation and the attenuation of inflammatory gene expression (iNOS and COX2); IKK, p38 and ERK activation were not changed (153). However, siRNA-mediated knockdown of Syk in RAW 264.7 cells followed by treatment with LPS, CpG, or poly(I:C) did not result in changes to JNK activation although there was an observed increase in iNOS and COX-2 expression (153). Chaudhary et al. treated human monocyte THP-1 cells with piceatannol and found that Syk activity is necessary for TLR4 tyrosine phosphorylation upon LPS stimulation and that piceatannol treatment results in an inhibition of IL-10 and IL-12 release from the THP-1 cells upon LPS stimulation (154).
Poppy genotyping is performed by amplifying the region containing the mutation using PCR, followed by sequencing of the amplified region to detect the single nucleotide transition. The same primers are used for PCR amplification and for sequencing.
Poppy(F): 5’- CCGCCGTCCACTCTTGGTAATG-3’
Poppy(R): 5’- TGTTTCAAAGCAAGTTGACGCAAGC-3’
Poppy_seq(F): 5’- CAGGTTTCCATGGGGATGAA-3’
1) 94°C 2:00
2) 94°C 0:30
3) 55°C 0:30
4) 72°C 1:00
5) repeat steps (2-4) 40X
6) 72°C 10:00
7) 4°C ∞
The following sequence of 797 nucleotides (from Genbank genomic region NC_000079 for the linear DNA sequence of Syk) is amplified:
57130 c cgccgtccac tcttggtaat gatgtcgtgt gattctaggc acattaagga
57181 taagaacatc atagagctgg ttcaccaggt ttccatgggg atgaagtatt tggaagagag
57241 caactttgtg cacagagatc tggctgcgcg gaacgtgctt ctggtcacac agcactatgc
57301 caagatcagc gatttcggtc tttccaaagc cctgcgtgct gatgaaaact actacaaggt
57361 aggagcgctc ggtgcaagct cacagaacag ggagaggaaa cagctctgtg caggctcacg
57421 gagcaggctg agagctcagt acaggctcac agagcagctg aggggacagc ttccatgcat
57481 agttaaggtt gcaggttata aagatataga aagataaatg tgtgctctct gtattttact
57541 atggtagaaa tctcactagt aaccttggag aaaagtattc ttaagatcga ttctgtccat
57601 caagaaacac aaaccaaaaa tactgtaatg tttctcaact ggaatctttt tcagactagg
57661 atcttatgtt gagttttttg gtggtggtgg tggttttttt tttttttttt ttcgttttac
57721 atttacttat cttgctctgt gtatggagtc atgtgtgccg tagtgttcta atagagagca
57781 gaggacaact tacagaagtt gattctctcc atctaccatg catatcggag gaatcgaact
57841 ctgatcttcg gattcggcag caggcacctt acccattgag ccatcttgct ggcctctaaa
57901 tgcttgcgtc aacttgcttt gaaaca
Primer binding sites are underlined and the sequencing primer is highlighted; the mutated A is shown in red text.
1. Sada, K., Takano, T., Yanagi, S., and Yamamura, H. (2001) Structure and Function of Syk Protein-Tyrosine Kinase. J Biochem. 130, 177-186.
2. Tohyama, Y., and Yamamura, H. (2009) Protein Tyrosine Kinase, Syk: A Key Player in Phagocytic Cells. J Biochem. 145, 267-273.
3. Mocsai, A., Ruland, J., and Tybulewicz, V. L. (2010) The SYK Tyrosine Kinase: A Crucial Player in Diverse Biological Functions. Nat Rev Immunol. 10, 387-402.
4. Yanagi, S., Inatome, R., Takano, T., and Yamamura, H. (2001) Syk Expression and Novel Function in a Wide Variety of Tissues. Biochem Biophys Res Commun. 288, 495-498.
5. Riccaboni, M., Bianchi, I., and Petrillo, P. (2010) Spleen Tyrosine Kinases: Biology, Therapeutic Targets and Drugs. Drug Discov Today. 15, 517-530.
7. Kumaran, S., Grucza, R. A., and Waksman, G. (2003) The Tandem Src Homology 2 Domain of the Syk Kinase: A Molecular Device that Adapts to Interphosphotyrosine Distances. Proc Natl Acad Sci U S A. 100, 14828-14833.
8. Adachi, T., Wienands, J., Tsubata, T., and Kurosaki, T. (2007) Interdomain A is Crucial for ITAM-Dependent and -Independent Regulation of Syk. Biochem Biophys Res Commun. 364, 111-117.
9. Law, C. L., Chandran, K. A., Sidorenko, S. P., and Clark, E. A. (1996) Phospholipase C-gamma1 Interacts with Conserved Phosphotyrosyl Residues in the Linker Region of Syk and is a Substrate for Syk. Mol Cell Biol. 16, 1305-1315.
10. Hong, J. J., Yankee, T. M., Harrison, M. L., and Geahlen, R. L. (2002) Regulation of Signaling in B Cells through the Phosphorylation of Syk on Linker Region Tyrosines. A Mechanism for Negative Signaling by the Lyn Tyrosine Kinase. J Biol Chem. 277, 31703-31714.
11. Simon, M., Vanes, L., Geahlen, R. L., and Tybulewicz, V. L. (2005) Distinct Roles for the Linker Region Tyrosines of Syk in FcepsilonRI Signaling in Primary Mast Cells. J Biol Chem. 280, 4510-4517.
12. Latour, S., Zhang, J., Siraganian, R. P., and Veillette, A. (1998) A Unique Insert in the Linker Domain of Syk is Necessary for its Function in Immunoreceptor Signalling. EMBO J. 17, 2584-2595.
13. Zhang, J., Berenstein, E., and Siraganian, R. P. (2002) Phosphorylation of Tyr342 in the Linker Region of Syk is Critical for Fc Epsilon RI Signaling in Mast Cells. Mol Cell Biol. 22, 8144-8154.
14. Turner, M., Schweighoffer, E., Colucci, F., Di Santo, J. P., and Tybulewicz, V. L. (2000) Tyrosine Kinase SYK: Essential Functions for Immunoreceptor Signalling. Immunol Today. 21, 148-154.
15. Wang, L., Duke, L., Zhang, P. S., Arlinghaus, R. B., Symmans, W. F., Sahin, A., Mendez, R., and Dai, J. L. (2003) Alternative Splicing Disrupts a Nuclear Localization Signal in Spleen Tyrosine Kinase that is Required for Invasion Suppression in Breast Cancer. Cancer Res. 63, 4724-4730.
16. Zhou, F., Hu, J., Ma, H., Harrison, M. L., and Geahlen, R. L. (2006) Nucleocytoplasmic Trafficking of the Syk Protein Tyrosine Kinase. Mol Cell Biol. 26, 3478-3491.
17. Rowley, R. B., Bolen, J. B., and Fargnoli, J. (1995) Molecular Cloning of Rodent p72Syk. Evidence of Alternative mRNA Splicing. J Biol Chem. 270, 12659-12664.
18. Bohnenberger, H., Oellerich, T., Engelke, M., Hsiao, H. H., Urlaub, H., and Wienands, J. (2011) Complex Phosphorylation Dynamics Control the Composition of the Syk Interactome in B Cells. Eur J Immunol. 41, 1550-1562.
19. Furlong, M. T., Mahrenholz, A. M., Kim, K. H., Ashendel, C. L., Harrison, M. L., and Geahlen, R. L. (1997) Identification of the Major Sites of Autophosphorylation of the Murine Protein-Tyrosine Kinase Syk. Biochim Biophys Acta. 1355, 177-190.
20. Keshvara, L. M., Isaacson, C., Harrison, M. L., and Geahlen, R. L. (1997) Syk Activation and Dissociation from the B-Cell Antigen Receptor is Mediated by Phosphorylation of Tyrosine 130. J Biol Chem. 272, 10377-10381.
21. Lupher, M. L.,Jr, Rao, N., Lill, N. L., Andoniou, C. E., Miyake, S., Clark, E. A., Druker, B., and Band, H. (1998) Cbl-Mediated Negative Regulation of the Syk Tyrosine Kinase. A Critical Role for Cbl Phosphotyrosine-Binding Domain Binding to Syk Phosphotyrosine 323. J Biol Chem. 273, 35273-35281.
22. Yankee, T. M., Keshvara, L. M., Sawasdikosol, S., Harrison, M. L., and Geahlen, R. L. (1999) Inhibition of Signaling through the B Cell Antigen Receptor by the Protooncogene Product, c-Cbl, Requires Syk Tyrosine 317 and the c-Cbl Phosphotyrosine-Binding Domain. J Immunol. 163, 5827-5835.
23. Sada, K., Zhang, J., and Siraganian, R. P. (2000) Point Mutation of a Tyrosine in the Linker Region of Syk Results in a Gain of Function. J Immunol. 164, 338-344.
24. Meng, W., Sawasdikosol, S., Burakoff, S. J., and Eck, M. J. (1999) Structure of the Amino-Terminal Domain of Cbl Complexed to its Binding Site on ZAP-70 Kinase. Nature. 398, 84-90.
25. Bottini, N., Stefanini, L., Williams, S., Alonso, A., Jascur, T., Abraham, R. T., Couture, C., and Mustelin, T. (2002) Activation of ZAP-70 through Specific Dephosphorylation at the Inhibitory Tyr-292 by the Low Molecular Weight Phosphotyrosine Phosphatase (LMPTP). J Biol Chem. 277, 24220-24224.
26. Kong, G., Dalton, M., Bubeck Wardenburg, J., Straus, D., Kurosaki, T., and Chan, A. C. (1996) Distinct Tyrosine Phosphorylation Sites in ZAP-70 Mediate Activation and Negative Regulation of Antigen Receptor Function. Mol Cell Biol. 16, 5026-5035.
27. Deckert, M., Tartare-Deckert, S., Couture, C., Mustelin, T., and Altman, A. (1996) Functional and Physical Interactions of Syk Family Kinases with the Vav Proto-Oncogene Product. Immunity. 5, 591-604.
28. Kurosaki, T., and Tsukada, S. (2000) BLNK: Connecting Syk and Btk to Calcium Signals. Immunity. 12, 1-5.
29. Finco, T. S., Kadlecek, T., Zhang, W., Samelson, L. E., and Weiss, A. (1998) LAT is Required for TCR-Mediated Activation of PLCgamma1 and the Ras Pathway. Immunity. 9, 617-626.
30. Moon, K. D., Post, C. B., Durden, D. L., Zhou, Q., De, P., Harrison, M. L., and Geahlen, R. L. (2005) Molecular Basis for a Direct Interaction between the Syk Protein-Tyrosine Kinase and Phosphoinositide 3-Kinase. J Biol Chem. 280, 1543-1551.
31. Kulathu, Y., Hobeika, E., Turchinovich, G., and Reth, M. (2008) The Kinase Syk as an Adaptor Controlling Sustained Calcium Signalling and B-Cell Development. EMBO J. 27, 1333-1344.
32. Hubbard, S. R., Wei, L., Ellis, L., and Hendrickson, W. A. (1994) Crystal Structure of the Tyrosine Kinase Domain of the Human Insulin Receptor. Nature. 372, 746-754.
33. Kurosaki, T., Johnson, S. A., Pao, L., Sada, K., Yamamura, H., and Cambier, J. C. (1995) Role of the Syk Autophosphorylation Site and SH2 Domains in B Cell Antigen Receptor Signaling. J Exp Med. 182, 1815-1823.
34. Zhang, J., Kimura, T., and Siraganian, R. P. (1998) Mutations in the Activation Loop Tyrosines of Protein Tyrosine Kinase Syk Abrogate Intracellular Signaling but Not Kinase Activity. J Immunol. 161, 4366-4374.
35. Carsetti, L., Laurenti, L., Gobessi, S., Longo, P. G., Leone, G., and Efremov, D. G. (2009) Phosphorylation of the Activation Loop Tyrosines is Required for Sustained Syk Signaling and Growth Factor-Independent B-Cell Proliferation. Cell Signal. 21, 1187-1194.
36. Kulathu, Y., Grothe, G., and Reth, M. (2009) Autoinhibition and Adapter Function of Syk. Immunol Rev. 232, 286-299.
37. Zeitlmann, L., Knorr, T., Knoll, M., Romeo, C., Sirim, P., and Kolanus, W. (1998) T Cell Activation Induced by Novel Gain-of-Function Mutants of Syk and ZAP-70. J Biol Chem. 273, 15445-15452.
38. Deindl, S., Kadlecek, T. A., Brdicka, T., Cao, X., Weiss, A., and Kuriyan, J. (2007) Structural Basis for the Inhibition of Tyrosine Kinase Activity of ZAP-70. Cell. 129, 735-746.
39. Tsang, E., Giannetti, A. M., Shaw, D., Dinh, M., Tse, J. K., Gandhi, S., Ho, H., Wang, S., Papp, E., and Bradshaw, J. M. (2008) Molecular Mechanism of the Syk Activation Switch. J Biol Chem. 283, 32650-32659.
40. Atwell, S., Adams, J. M., Badger, J., Buchanan, M. D., Feil, I. K., Froning, K. J., Gao, X., Hendle, J., Keegan, K., Leon, B. C., Muller-Dieckmann, H. J., Nienaber, V. L., Noland, B. W., Post, K., Rajashankar, K. R., Ramos, A., Russell, M., Burley, S. K., and Buchanan, S. G. (2004) A Novel Mode of Gleevec Binding is Revealed by the Structure of Spleen Tyrosine Kinase. J Biol Chem. 279, 55827-55832.
41. Gradler, U., Schwarz, D., Dresing, V., Musil, D., Bomke, J., Frech, M., Greiner, H., Jakel, S., Rysiok, T., Muller-Pompalla, D., and Wegener, A. (2013) Structural and Biophysical Characterization of the Syk Activation Switch. J Mol Biol. 425, 309-333.
42. Ma, H., Yankee, T. M., Hu, J., Asai, D. J., Harrison, M. L., and Geahlen, R. L. (2001) Visualization of Syk-Antigen Receptor Interactions using Green Fluorescent Protein: Differential Roles for Syk and Lyn in the Regulation of Receptor Capping and Internalization. J Immunol. 166, 1507-1516.
43. Hoellenriegel, J., Coffey, G. P., Sinha, U., Pandey, A., Sivina, M., Ferrajoli, A., Ravandi, F., Wierda, W. G., O'Brien, S., Keating, M. J., and Burger, J. A. (2012) Selective, Novel Spleen Tyrosine Kinase (Syk) Inhibitors Suppress Chronic Lymphocytic Leukemia B-Cell Activation and Migration. Leukemia. 26, 1576-1583.
44. Carnevale, J., Ross, L., Puissant, A., Banerji, V., Stone, R. M., Deangelo, D. J., Ross, K. N., and Stegmaier, K. (2013) SYK Regulates mTOR Signaling in AML. Leukemia. .
45. Fruchon, S., Kheirallah, S., Al Saati, T., Ysebaert, L., Laurent, C., Leseux, L., Fournie, J. J., Laurent, G., and Bezombes, C. (2012) Involvement of the Syk-mTOR Pathway in Follicular Lymphoma Cell Invasion and Angiogenesis. Leukemia. 26, 795-805.
46. Leseux, L., Hamdi, S. M., Al Saati, T., Capilla, F., Recher, C., Laurent, G., and Bezombes, C. (2006) Syk-Dependent mTOR Activation in Follicular Lymphoma Cells. Blood. 108, 4156-4162.
47. Coopman, P. J., Do, M. T., Barth, M., Bowden, E. T., Hayes, A. J., Basyuk, E., Blancato, J. K., Vezza, P. R., McLeskey, S. W., Mangeat, P. H., and Mueller, S. C. (2000) The Syk Tyrosine Kinase Suppresses Malignant Growth of Human Breast Cancer Cells. Nature. 406, 742-747.
48. Coopman, P. J., and Mueller, S. C. (2006) The Syk Tyrosine Kinase: A New Negative Regulator in Tumor Growth and Progression. Cancer Lett. 241, 159-173.
49. Turner, M., Mee, P. J., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Furlong, M. T., Geahlen, R. L., and Tybulewicz, V. L. (1995) Perinatal Lethality and Blocked B-Cell Development in Mice Lacking the Tyrosine Kinase Syk. Nature. 378, 298-302.
50. Saijo, K., Schmedt, C., Su, I. H., Karasuyama, H., Lowell, C. A., Reth, M., Adachi, T., Patke, A., Santana, A., and Tarakhovsky, A. (2003) Essential Role of Src-Family Protein Tyrosine Kinases in NF-kappaB Activation during B Cell Development. Nat Immunol. 4, 274-279.
51. Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B., and Pawson, T. (1995) Syk Tyrosine Kinase Required for Mouse Viability and B-Cell Development. Nature. 378, 303-306.
52. Geahlen, R. L. (2009) Syk and pTyr'd: Signaling through the B Cell Antigen Receptor. Biochim Biophys Acta. 1793, 1115-1127.
53. Rolli, V., Gallwitz, M., Wossning, T., Flemming, A., Schamel, W. W., Zurn, C., and Reth, M. (2002) Amplification of B Cell Antigen Receptor Signaling by a Syk/ITAM Positive Feedback Loop. Mol Cell. 10, 1057-1069.
54. Hashimoto, S., Iwamatsu, A., Ishiai, M., Okawa, K., Yamadori, T., Matsushita, M., Baba, Y., Kishimoto, T., Kurosaki, T., and Tsukada, S. (1999) Identification of the SH2 Domain Binding Protein of Bruton's Tyrosine Kinase as BLNK--Functional Significance of Btk-SH2 Domain in B-Cell Antigen Receptor-Coupled Calcium Signaling. Blood. 94, 2357-2364.
55. Koretzky, G. A., Abtahian, F., and Silverman, M. A. (2006) SLP76 and SLP65: Complex Regulation of Signalling in Lymphocytes and Beyond. Nat Rev Immunol. 6, 67-78.
56. Guo, B., Su, T. T., and Rawlings, D. J. (2004) Protein Kinase C Family Functions in B-Cell Activation. Curr Opin Immunol. 16, 367-373.
57. Hara, H., Wada, T., Bakal, C., Kozieradzki, I., Suzuki, S., Suzuki, N., Nghiem, M., Griffiths, E. K., Krawczyk, C., Bauer, B., D'Acquisto, F., Ghosh, S., Yeh, W. C., Baier, G., Rottapel, R., and Penninger, J. M. (2003) The MAGUK Family Protein CARD11 is Essential for Lymphocyte Activation. Immunity. 18, 763-775.
58. Ruland, J., Duncan, G. S., Elia, A., del, B. B.,I, Nguyen, L., Plyte, S., Millar, D. G., Bouchard, D., Wakeham, A., Ohashi, P. S., and Mak, T. W. (2001) Bcl10 is a Positive Regulator of Antigen Receptor-Induced Activation of NF-kappaB and Neural Tube Closure. Cell. 104, 33-42.
59. Newton, K., and Dixit, V. M. (2003) Mice Lacking the CARD of CARMA1 Exhibit Defective B Lymphocyte Development and Impaired Proliferation of their B and T Lymphocytes. Curr Biol. 13, 1247-1251.
60. Egawa, T., Albrecht, B., Favier, B., Sunshine, M. J., Mirchandani, K., O'Brien, W., Thome, M., and Littman, D. R. (2003) Requirement for CARMA1 in Antigen Receptor-Induced NF-Kappa B Activation and Lymphocyte Proliferation. Curr Biol. 13, 1252-1258.
61. Okada, T., Maeda, A., Iwamatsu, A., Gotoh, K., and Kurosaki, T. (2000) BCAP: The Tyrosine Kinase Substrate that Connects B Cell Receptor to Phosphoinositide 3-Kinase Activation. Immunity. 13, 817-827.
62. Ding, J., Takano, T., Gao, S., Han, W., Noda, C., Yanagi, S., and Yamamura, H. (2000) Syk is Required for the Activation of Akt Survival Pathway in B Cells Exposed to Oxidative Stress. J Biol Chem. 275, 30873-30877.
63. Rao, N., Ghosh, A. K., Ota, S., Zhou, P., Reddi, A. L., Hakezi, K., Druker, B. K., Wu, J., and Band, H. (2001) The Non-Receptor Tyrosine Kinase Syk is a Target of Cbl-Mediated Ubiquitylation upon B-Cell Receptor Stimulation. EMBO J. 20, 7085-7095.
64. Jiang, A., Craxton, A., Kurosaki, T., and Clark, E. A. (1998) Different Protein Tyrosine Kinases are Required for B Cell Antigen Receptor-Mediated Activation of Extracellular Signal-Regulated Kinase, c-Jun NH2-Terminal Kinase 1, and p38 Mitogen-Activated Protein Kinase. J Exp Med. 188, 1297-1306.
65. Hitomi, T., Yanagi, S., Inatome, R., and Yamamura, H. (1999) Cross-Linking of the B Cell Receptor Induces Activation of Phospholipase D through Syk, Btk and Phospholipase C-gamma2. FEBS Lett. 445, 371-374.
66. Gross, B. S., Melford, S. K., and Watson, S. P. (1999) Evidence that Phospholipase C-gamma2 Interacts with SLP-76, Syk, Lyn, LAT and the Fc Receptor Gamma-Chain After Stimulation of the Collagen Receptor Glycoprotein VI in Human Platelets. Eur J Biochem. 263, 612-623.
67. Baba, Y., Hashimoto, S., Matsushita, M., Watanabe, D., Kishimoto, T., Kurosaki, T., and Tsukada, S. (2001) BLNK Mediates Syk-Dependent Btk Activation. Proc Natl Acad Sci U S A. 98, 2582-2586.
68. Craxton, A., Jiang, A., Kurosaki, T., and Clark, E. A. (1999) Syk and Bruton's Tyrosine Kinase are Required for B Cell Antigen Receptor-Mediated Activation of the Kinase Akt. J Biol Chem. 274, 30644-30650.
69. Miranti, C. K., Leng, L., Maschberger, P., Brugge, J. S., and Shattil, S. J. (1998) Identification of a Novel Integrin Signaling Pathway Involving the Kinase Syk and the Guanine Nucleotide Exchange Factor Vav1. Curr Biol. 8, 1289-1299.
70. Takada, Y., and Aggarwal, B. B. (2004) TNF Activates Syk Protein Tyrosine Kinase Leading to TNF-Induced MAPK Activation, NF-kappaB Activation, and Apoptosis. J Immunol. 173, 1066-1077.
71. Jiang, Y., and Cheng, H. (2007) Evidence of LAT as a Dual Substrate for Lck and Syk in T Lymphocytes. Leuk Res. 31, 541-545.
72. Abtahian, F., Guerriero, A., Sebzda, E., Lu, M. M., Zhou, R., Mocsai, A., Myers, E. E., Huang, B., Jackson, D. G., Ferrari, V. A., Tybulewicz, V., Lowell, C. A., Lepore, J. J., Koretzky, G. A., and Kahn, M. L. (2003) Regulation of Blood and Lymphatic Vascular Separation by Signaling Proteins SLP-76 and Syk. Science. 299, 247-251.
73. Reeve, J. L., Zou, W., Liu, Y., Maltzman, J. S., Ross, F. P., and Teitelbaum, S. L. (2009) SLP-76 Couples Syk to the Osteoclast Cytoskeleton. J Immunol. 183, 1804-1812.
74. Gross, B. S., Lee, J. R., Clements, J. L., Turner, M., Tybulewicz, V. L., Findell, P. R., Koretzky, G. A., and Watson, S. P. (1999) Tyrosine Phosphorylation of SLP-76 is Downstream of Syk Following Stimulation of the Collagen Receptor in Platelets. J Biol Chem. 274, 5963-5971.
75. Fu, C., Turck, C. W., Kurosaki, T., and Chan, A. C. (1998) BLNK: A Central Linker Protein in B Cell Activation. Immunity. 9, 93-103.
76. Ishiai, M., Kurosaki, M., Pappu, R., Okawa, K., Ronko, I., Fu, C., Shibata, M., Iwamatsu, A., Chan, A. C., and Kurosaki, T. (1999) BLNK Required for Coupling Syk to PLC Gamma 2 and Rac1-JNK in B Cells. Immunity. 10, 117-125.
77. Beitz, L. O., Fruman, D. A., Kurosaki, T., Cantley, L. C., and Scharenberg, A. M. (1999) SYK is Upstream of Phosphoinositide 3-Kinase in B Cell Receptor Signaling. J Biol Chem. 274, 32662-32666.
78. Hao, J. J., Carey, G. B., and Zhan, X. (2004) Syk-Mediated Tyrosine Phosphorylation is Required for the Association of Hematopoietic Lineage Cell-Specific Protein 1 with Lipid Rafts and B Cell Antigen Receptor Signalosome Complex. J Biol Chem. 279, 33413-33420.
79. Kahner, B. N., Dorsam, R. T., Mada, S. R., Kim, S., Stalker, T. J., Brass, L. F., Daniel, J. L., Kitamura, D., and Kunapuli, S. P. (2007) Hematopoietic Lineage Cell Specific Protein 1 (HS1) is a Functionally Important Signaling Molecule in Platelet Activation. Blood. 110, 2449-2456.
80. Ruzzene, M., Brunati, A. M., Marin, O., Donella-Deana, A., and Pinna, L. A. (1996) SH2 Domains Mediate the Sequential Phosphorylation of HS1 Protein by p72syk and Src-Related Protein Tyrosine Kinases. Biochemistry. 35, 5327-5332.
81. Gross, O., Gewies, A., Finger, K., Schafer, M., Sparwasser, T., Peschel, C., Forster, I., and Ruland, J. (2006) Card9 Controls a Non-TLR Signalling Pathway for Innate Anti-Fungal Immunity. Nature. 442, 651-656.
82. Gross, O., Poeck, H., Bscheider, M., Dostert, C., Hannesschlager, N., Endres, S., Hartmann, G., Tardivel, A., Schweighoffer, E., Tybulewicz, V., Mocsai, A., Tschopp, J., and Ruland, J. (2009) Syk Kinase Signalling Couples to the Nlrp3 Inflammasome for Anti-Fungal Host Defence. Nature. 459, 433-436.
83. Moreno-Garcia, M. E., Sommer, K. M., Bandaranayake, A. D., and Rawlings, D. J. (2006) Proximal Signals Controlling B-Cell Antigen Receptor (BCR) Mediated NF-kappaB Activation. Adv Exp Med Biol. 584, 89-106.
84. Jabril-Cuenod, B., Zhang, C., Scharenberg, A. M., Paolini, R., Numerof, R., Beaven, M. A., and Kinet, J. P. (1996) Syk-Dependent Phosphorylation of Shc. A Potential Link between FcepsilonRI and the Ras/mitogen-Activated Protein Kinase Signaling Pathway through SOS and Grb2. J Biol Chem. 271, 16268-16272.
85. Angibaud, J., Louveau, A., Baudouin, S. J., Nerriere-Daguin, V., Evain, S., Bonnamain, V., Hulin, P., Csaba, Z., Dournaud, P., Thinard, R., Naveilhan, P., Noraz, N., Pellier-Monnin, V., and Boudin, H. (2011) The Immune Molecule CD3zeta and its Downstream Effectors ZAP-70/Syk Mediate Ephrin Signaling in Neurons to Regulate Early Neuritogenesis. J Neurochem. 119, 708-722.
86. Shukla, U., Hatani, T., Nakashima, K., Ogi, K., and Sada, K. (2009) Tyrosine Phosphorylation of 3BP2 Regulates B Cell Receptor-Mediated Activation of NFAT. J Biol Chem. 284, 33719-33728.
87. Chen, G., Dimitriou, I. D., La Rose, J., Ilangumaran, S., Yeh, W. C., Doody, G., Turner, M., Gommerman, J., and Rottapel, R. (2007) The 3BP2 Adapter Protein is Required for Optimal B-Cell Activation and Thymus-Independent Type 2 Humoral Response. Mol Cell Biol. 27, 3109-3122.
88. Han, C., Jin, J., Xu, S., Liu, H., Li, N., and Cao, X. (2010) Integrin CD11b Negatively Regulates TLR-Triggered Inflammatory Responses by Activating Syk and Promoting Degradation of MyD88 and TRIF Via Cbl-b. Nat Immunol. 11, 734-742.
89. Palacios, E. H., and Weiss, A. (2007) Distinct Roles for Syk and ZAP-70 during Early Thymocyte Development. J Exp Med. 204, 1703-1715.
90. Latour, S., Fournel, M., and Veillette, A. (1997) Regulation of T-Cell Antigen Receptor Signalling by Syk Tyrosine Protein Kinase. Mol Cell Biol. 17, 4434-4441.
91. Mallick-Wood, C. A., Pao, W., Cheng, A. M., Lewis, J. M., Kulkarni, S., Bolen, J. B., Rowley, B., Tigelaar, R. E., Pawson, T., and Hayday, A. C. (1996) Disruption of Epithelial Gamma Delta T Cell Repertoires by Mutation of the Syk Tyrosine Kinase. Proc Natl Acad Sci U S A. 93, 9704-9709.
92. Brumbaugh, K. M., Binstadt, B. A., Billadeau, D. D., Schoon, R. A., Dick, C. J., Ten, R. M., and Leibson, P. J. (1997) Functional Role for Syk Tyrosine Kinase in Natural Killer Cell-Mediated Natural Cytotoxicity. J Exp Med. 186, 1965-1974.
93. Kiefer, F., Brumell, J., Al-Alawi, N., Latour, S., Cheng, A., Veillette, A., Grinstein, S., and Pawson, T. (1998) The Syk Protein Tyrosine Kinase is Essential for Fcgamma Receptor Signaling in Macrophages and Neutrophils. Mol Cell Biol. 18, 4209-4220.
94. Crowley, M. T., Costello, P. S., Fitzer-Attas, C. J., Turner, M., Meng, F., Lowell, C., Tybulewicz, V. L., and DeFranco, A. L. (1997) A Critical Role for Syk in Signal Transduction and Phagocytosis Mediated by Fcgamma Receptors on Macrophages. J Exp Med. 186, 1027-1039.
95. Lowell, C. A. (2011) Src-Family and Syk Kinases in Activating and Inhibitory Pathways in Innate Immune Cells: Signaling Cross Talk. Cold Spring Harb Perspect Biol. 3, 10.1101/cshperspect.a002352.
96. Xu, S., Huo, J., Gunawan, M., Su, I. H., and Lam, K. P. (2009) Activated Dectin-1 Localizes to Lipid Raft Microdomains for Signaling and Activation of Phagocytosis and Cytokine Production in Dendritic Cells. J Biol Chem. 284, 22005-22011.
97. Kim, H., and Koh, G. Y. (2010) Platelets Take the Lead in Lymphatic Separation. Circ Res. 106, 1184-1186.
98. Finney, B. A., Schweighoffer, E., Navarro-Nunez, L., Benezech, C., Barone, F., Hughes, C. E., Langan, S. A., Lowe, K. L., Pollitt, A. Y., Mourao-Sa, D., Sheardown, S., Nash, G. B., Smithers, N., Reis e Sousa, C., Tybulewicz, V. L., and Watson, S. P. (2012) CLEC-2 and Syk in the megakaryocytic/platelet Lineage are Essential for Development. Blood. 119, 1747-1756.
99. Kerrigan, A. M., and Brown, G. D. (2010) Syk-Coupled C-Type Lectin Receptors that Mediate Cellular Activation Via Single Tyrosine Based Activation Motifs. Immunol Rev. 234, 335-352.
100. Klesney-Tait, J., Turnbull, I. R., and Colonna, M. (2006) The TREM Receptor Family and Signal Integration. Nat Immunol. 7, 1266-1273.
101. Inui, M., Kikuchi, Y., Aoki, N., Endo, S., Maeda, T., Sugahara-Tobinai, A., Fujimura, S., Nakamura, A., Kumanogoh, A., Colonna, M., and Takai, T. (2009) Signal Adaptor DAP10 Associates with MDL-1 and Triggers Osteoclastogenesis in Cooperation with DAP12. Proc Natl Acad Sci U S A. 106, 4816-4821.
102. Yamasaki, S., Ishikawa, E., Sakuma, M., Hara, H., Ogata, K., and Saito, T. (2008) Mincle is an ITAM-Coupled Activating Receptor that Senses Damaged Cells. Nat Immunol. 9, 1179-1188.
103. Sato, K., Yang, X. L., Yudate, T., Chung, J. S., Wu, J., Luby-Phelps, K., Kimberly, R. P., Underhill, D., Cruz, P. D.,Jr, and Ariizumi, K. (2006) Dectin-2 is a Pattern Recognition Receptor for Fungi that Couples with the Fc Receptor Gamma Chain to Induce Innate Immune Responses. J Biol Chem. 281, 38854-38866.
104. Zou, W., Reeve, J. L., Liu, Y., Teitelbaum, S. L., and Ross, F. P. (2008) DAP12 Couples c-Fms Activation to the Osteoclast Cytoskeleton by Recruitment of Syk. Mol Cell. 31, 422-431.
105. Otero, K., Turnbull, I. R., Poliani, P. L., Vermi, W., Cerutti, E., Aoshi, T., Tassi, I., Takai, T., Stanley, S. L., Miller, M., Shaw, A. S., and Colonna, M. (2009) Macrophage Colony-Stimulating Factor Induces the Proliferation and Survival of Macrophages Via a Pathway Involving DAP12 and Beta-Catenin. Nat Immunol. 10, 734-743.
106. Zou, W., Kitaura, H., Reeve, J., Long, F., Tybulewicz, V. L., Shattil, S. J., Ginsberg, M. H., Ross, F. P., and Teitelbaum, S. L. (2007) Syk, c-Src, the alphavbeta3 Integrin, and ITAM Immunoreceptors, in Concert, Regulate Osteoclastic Bone Resorption. J Cell Biol. 176, 877-888.
107. Mocsai, A., Abram, C. L., Jakus, Z., Hu, Y., Lanier, L. L., and Lowell, C. A. (2006) Integrin Signaling in Neutrophils and Macrophages Uses Adaptors Containing Immunoreceptor Tyrosine-Based Activation Motifs. Nat Immunol. 7, 1326-1333.
108. Hamerman, J. A., Ni, M., Killebrew, J. R., Chu, C. L., and Lowell, C. A. (2009) The Expanding Roles of ITAM Adapters FcRgamma and DAP12 in Myeloid Cells. Immunol Rev. 232, 42-58.
109. Ivashkiv, L. B. (2009) Cross-Regulation of Signaling by ITAM-Associated Receptors. Nat Immunol. 10, 340-347.
110. Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., and Seaman, W. E. (2009) A Role for TREM2 Ligands in the Phagocytosis of Apoptotic Neuronal Cells by Microglia. J Neurochem. 109, 1144-1156.
111. Mocsai, A., Humphrey, M. B., Van Ziffle, J. A., Hu, Y., Burghardt, A., Spusta, S. C., Majumdar, S., Lanier, L. L., Lowell, C. A., and Nakamura, M. C. (2004) The Immunomodulatory Adapter Proteins DAP12 and Fc Receptor Gamma-Chain (FcRgamma) Regulate Development of Functional Osteoclasts through the Syk Tyrosine Kinase. Proc Natl Acad Sci U S A. 101, 6158-6163.
112. Ford, J. W., and McVicar, D. W. (2009) TREM and TREM-Like Receptors in Inflammation and Disease. Curr Opin Immunol. 21, 38-46.
113. Krishnan, S., Warke, V. G., Nambiar, M. P., Tsokos, G. C., and Farber, D. L. (2003) The FcR Gamma Subunit and Syk Kinase Replace the CD3 Zeta-Chain and ZAP-70 Kinase in the TCR Signaling Complex of Human Effector CD4 T Cells. J Immunol. 170, 4189-4195.
114. Bryceson, Y. T., and Long, E. O. (2008) Line of Attack: NK Cell Specificity and Integration of Signals. Curr Opin Immunol. 20, 344-352.
115. Cornall, R. J., Cheng, A. M., Pawson, T., and Goodnow, C. C. (2000) Role of Syk in B-Cell Development and Antigen-Receptor Signaling. Proc Natl Acad Sci U S A. 97, 1713-1718.
116. Muta, T., Kurosaki, T., Misulovin, Z., Sanchez, M., Nussenzweig, M. C., and Ravetch, J. V. (1994) A 13-Amino-Acid Motif in the Cytoplasmic Domain of Fc Gamma RIIB Modulates B-Cell Receptor Signalling. Nature. 368, 70-73.
117. Mocsai, A., Zhou, M., Meng, F., Tybulewicz, V. L., and Lowell, C. A. (2002) Syk is Required for Integrin Signaling in Neutrophils. Immunity. 16, 547-558.
118. Ishmael, S. S., and MacGlashan, D. W.,Jr. (2010) Syk Expression in Peripheral Blood Leukocytes, CD34+ Progenitors, and CD34-Derived Basophils. J Leukoc Biol. 87, 291-300.
119. Kepley, C. L., Wilson, B. S., and Oliver, J. M. (1998) Identification of the Fc epsilonRI-Activated Tyrosine Kinases Lyn, Syk, and Zap-70 in Human Basophils. J Allergy Clin Immunol. 102, 304-315.
120. Yousefi, S., Hoessli, D. C., Blaser, K., Mills, G. B., and Simon, H. U. (1996) Requirement of Lyn and Syk Tyrosine Kinases for the Prevention of Apoptosis by Cytokines in Human Eosinophils. J Exp Med. 183, 1407-1414.
121. Costello, P. S., Turner, M., Walters, A. E., Cunningham, C. N., Bauer, P. H., Downward, J., and Tybulewicz, V. L. (1996) Critical Role for the Tyrosine Kinase Syk in Signalling through the High Affinity IgE Receptor of Mast Cells. Oncogene. 13, 2595-2605.
122. Matsubara, S., Li, G., Takeda, K., Loader, J. E., Pine, P., Masuda, E. S., Miyahara, N., Miyahara, S., Lucas, J. J., Dakhama, A., and Gelfand, E. W. (2006) Inhibition of Spleen Tyrosine Kinase Prevents Mast Cell Activation and Airway Hyperresponsiveness. Am J Respir Crit Care Med. 173, 56-63.
123. Sedlik, C., Orbach, D., Veron, P., Schweighoffer, E., Colucci, F., Gamberale, R., Ioan-Facsinay, A., Verbeek, S., Ricciardi-Castagnoli, P., Bonnerot, C., Tybulewicz, V. L., Di Santo, J., and Amigorena, S. (2003) A Critical Role for Syk Protein Tyrosine Kinase in Fc Receptor-Mediated Antigen Presentation and Induction of Dendritic Cell Maturation. J Immunol. 170, 846-852.
124. Poole, A., Gibbins, J. M., Turner, M., van Vugt, M. J., van de Winkel, J. G., Saito, T., Tybulewicz, V. L., and Watson, S. P. (1997) The Fc Receptor Gamma-Chain and the Tyrosine Kinase Syk are Essential for Activation of Mouse Platelets by Collagen. EMBO J. 16, 2333-2341.
125. Suzuki-Inoue, K., Fuller, G. L., Garcia, A., Eble, J. A., Pohlmann, S., Inoue, O., Gartner, T. K., Hughan, S. C., Pearce, A. C., Laing, G. D., Theakston, R. D., Schweighoffer, E., Zitzmann, N., Morita, T., Tybulewicz, V. L., Ozaki, Y., and Watson, S. P. (2006) A Novel Syk-Dependent Mechanism of Platelet Activation by the C-Type Lectin Receptor CLEC-2. Blood. 107, 542-549.
126. Obergfell, A., Eto, K., Mocsai, A., Buensuceso, C., Moores, S. L., Brugge, J. S., Lowell, C. A., and Shattil, S. J. (2002) Coordinate Interactions of Csk, Src, and Syk Kinases with [Alpha]IIb[Beta]3 Initiate Integrin Signaling to the Cytoskeleton. J Cell Biol. 157, 265-275.
127. Yamada, T., Fujieda, S., Yanagi, S., Yamamura, H., Inatome, R., Sunaga, H., and Saito, H. (2001) Protein-Tyrosine Kinase Syk Expressed in Human Nasal Fibroblasts and its Effect on RANTES Production. J Immunol. 166, 538-543.
128. Cha, H. S., Boyle, D. L., Inoue, T., Schoot, R., Tak, P. P., Pine, P., and Firestein, G. S. (2006) A Novel Spleen Tyrosine Kinase Inhibitor Blocks c-Jun N-Terminal Kinase-Mediated Gene Expression in Synoviocytes. J Pharmacol Exp Ther. 317, 571-578.
129. Ulanova, M., Puttagunta, L., Marcet-Palacios, M., Duszyk, M., Steinhoff, U., Duta, F., Kim, M. K., Indik, Z. K., Schreiber, A. D., and Befus, A. D. (2005) Syk Tyrosine Kinase Participates in beta1-Integrin Signaling and Inflammatory Responses in Airway Epithelial Cells. Am J Physiol Lung Cell Mol Physiol. 288, L497-507.
130. Tsuchida, S., Yanagi, S., Inatome, R., Ding, J., Hermann, P., Tsujimura, T., Matsui, N., and Yamamura, H. (2000) Purification of a 72-kDa Protein-Tyrosine Kinase from Rat Liver and its Identification as Syk: Involvement of Syk in Signaling Events of Hepatocytes. J Biochem. 127, 321-327.
131. Inatome, R., Yanagi, S., Takano, T., and Yamamura, H. (2001) A Critical Role for Syk in Endothelial Cell Proliferation and Migration. Biochem Biophys Res Commun. 286, 195-199.
132. Hoeller, C., Thallinger, C., Pratscher, B., Bister, M. D., Schicher, N., Loewe, R., Heere-Ress, E., Roka, F., Sexl, V., and Pehamberger, H. (2005) The Non-Receptor-Associated Tyrosine Kinase Syk is a Regulator of Metastatic Behavior in Human Melanoma Cells. J Invest Dermatol. 124, 1293-1299.
133. Mahabeleshwar, G. H., and Kundu, G. C. (2003) Syk, a Protein-Tyrosine Kinase, Suppresses the Cell Motility and Nuclear Factor Kappa B-Mediated Secretion of Urokinase Type Plasminogen Activator by Inhibiting the Phosphatidylinositol 3'-Kinase Activity in Breast Cancer Cells. J Biol Chem. 278, 6209-6221.
134. Tsujimura, T., Yanagi, S., Inatome, R., Takano, T., Ishihara, I., Mitsui, N., Takahashi, S., and Yamamura, H. (2001) Syk Protein-Tyrosine Kinase is Involved in Neuron-Like Differentiation of Embryonal Carcinoma P19 Cells. FEBS Lett. 489, 129-133.
135. Toyama, T., Iwase, H., Yamashita, H., Hara, Y., Omoto, Y., Sugiura, H., Zhang, Z., and Fujii, Y. (2003) Reduced Expression of the Syk Gene is Correlated with Poor Prognosis in Human Breast Cancer. Cancer Lett. 189, 97-102.
136. Chiorazzi, N., Rai, K. R., and Ferrarini, M. (2005) Chronic Lymphocytic Leukemia. N Engl J Med. 352, 804-815.
137. Baudot, A. D., Jeandel, P. Y., Mouska, X., Maurer, U., Tartare-Deckert, S., Raynaud, S. D., Cassuto, J. P., Ticchioni, M., and Deckert, M. (2009) The Tyrosine Kinase Syk Regulates the Survival of Chronic Lymphocytic Leukemia B Cells through PKCdelta and Proteasome-Dependent Regulation of Mcl-1 Expression. Oncogene. 28, 3261-3273.
138. Wong, B. R., Grossbard, E. B., Payan, D. G., and Masuda, E. S. (2004) Targeting Syk as a Treatment for Allergic and Autoimmune Disorders. Expert Opin Investig Drugs. 13, 743-762.
139. Bajpai, M., Chopra, P., Dastidar, S. G., and Ray, A. (2008) Spleen Tyrosine Kinase: A Novel Target for Therapeutic Intervention of Rheumatoid Arthritis. Expert Opin Investig Drugs. 17, 641-659.
140. Pamuk, O. N., and Tsokos, G. C. (2010) Spleen Tyrosine Kinase Inhibition in the Treatment of Autoimmune, Allergic and Autoinflammatory Diseases. Arthritis Res Ther. 12, 222.
141. Bohmer, R., Neuhaus, B., Buhren, S., Zhang, D., Stehling, M., Bock, B., and Kiefer, F. (2010) Regulation of Developmental Lymphangiogenesis by Syk(+) Leukocytes. Dev Cell. 18, 437-449.
142. Van Ziffle, J. A., and Lowell, C. A. (2009) Neutrophil-Specific Deletion of Syk Kinase Results in Reduced Host Defense to Bacterial Infection. Blood. 114, 4871-4882.
143. Sancho, D., Joffre, O. P., Keller, A. M., Rogers, N. C., Martinez, D., Hernanz-Falcon, P., Rosewell, I., and Reis e Sousa, C. (2009) Identification of a Dendritic Cell Receptor that Couples Sensing of Necrosis to Immunity. Nature. 458, 899-903.
144. Siegel, R., Kim, U., Patke, A., Yu, X., Ren, X., Tarakhovsky, A., and Roeder, R. G. (2006) Nontranscriptional Regulation of SYK by the Coactivator OCA-B is Required at Multiple Stages of B Cell Development. Cell. 125, 761-774.
145. Hamerman, J. A., Tchao, N. K., Lowell, C. A., and Lanier, L. L. (2005) Enhanced Toll-Like Receptor Responses in the Absence of Signaling Adaptor DAP12. Nat Immunol. 6, 579-586.
146. Avdi, N. J., Nick, J. A., Whitlock, B. B., Billstrom, M. A., Henson, P. M., Johnson, G. L., and Worthen, G. S. (2001) Tumor Necrosis Factor-Alpha Activation of the c-Jun N-Terminal Kinase Pathway in Human Neutrophils. Integrin Involvement in a Pathway Leading from Cytoplasmic Tyrosine Kinases Apoptosis. J Biol Chem. 276, 2189-2199.
147. Luo, B. H., Carman, C. V., and Springer, T. A. (2007) Structural Basis of Integrin Regulation and Signaling. Annu Rev Immunol. 25, 619-647.
148. Bezman, N., and Koretzky, G. A. (2007) Compartmentalization of ITAM and Integrin Signaling by Adapter Molecules. Immunol Rev. 218, 9-28.
149. Wang, L., Gordon, R. A., Huynh, L., Su, X., Park Min, K. H., Han, J., Arthur, J. S., Kalliolias, G. D., and Ivashkiv, L. B. (2010) Indirect Inhibition of Toll-Like Receptor and Type I Interferon Responses by ITAM-Coupled Receptors and Integrins. Immunity. 32, 518-530.
150. Sanjuan, M. A., Rao, N., Lai, K. T., Gu, Y., Sun, S., Fuchs, A., Fung-Leung, W. P., Colonna, M., and Karlsson, L. (2006) CpG-Induced Tyrosine Phosphorylation Occurs Via a TLR9-Independent Mechanism and is Required for Cytokine Secretion. J Cell Biol. 172, 1057-1068.
151. Ulanova, M., Asfaha, S., Stenton, G., Lint, A., Gilbertson, D., Schreiber, A., and Befus, D. (2007) Involvement of Syk Protein Tyrosine Kinase in LPS-Induced Responses in Macrophages. J Endotoxin Res. 13, 117-125.
152. Djoko, B., Chiou, R. Y., Shee, J. J., and Liu, Y. W. (2007) Characterization of Immunological Activities of Peanut Stilbenoids, Arachidin-1, Piceatannol, and Resveratrol on Lipopolysaccharide-Induced Inflammation of RAW 264.7 Macrophages. J Agric Food Chem. 55, 2376-2383.
153. Lin, Y. C., Huang, D. Y., Chu, C. L., and Lin, W. W. (2010) Anti-Inflammatory Actions of Syk Inhibitors in Macrophages Involve Non-Specific Inhibition of Toll-Like Receptors-Mediated JNK Signaling Pathway. Mol Immunol. 47, 1569-1578.
|Science Writers||Eva Marie Y. Moresco, Anne Murray|
|Authors||Ying Wang, Hexin Shi, Ming Zeng, Bruce Beutler|